Pacira BioSciences (PCRX) Cash from Operations (2010 - 2026)

Pacira BioSciences' Cash from Operations history runs 17 years deep, the most recent figure standing at 25680000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 27.58% year-over-year to 25680000.0; the TTM figure through Mar 2026 stood at 142215000.0 (down 19.08% YoY), while the FY2025 annual figure was 151994000.0, down 19.75% from the prior year.
• Cash from Operations was 25680000.0 for Q1 2026 at Pacira BioSciences, down from 43689000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 60834000.0 in Q3 2025 to a low of 12012000.0 in Q2 2025.
• Historically, Cash from Operations has averaged 39234470.59 across 5 years, with a median of 42654000.0 in 2022.
• The sharpest annual moves came in 2024 and 2025: Cash from Operations jumped 156.7% in 2024, then slumped 77.44% in 2025.
• A 5-year view of Cash from Operations shows it stood at 42037000.0 in 2022, then increased by 13.2% to 47584000.0 in 2023, then tumbled by 30.37% to 33132000.0 in 2024, then surged by 31.86% to 43689000.0 in 2025, then sank by 41.22% to 25680000.0 in 2026.
• The last three Cash from Operations figures came in at 25680000.0 (Q1 2026), 43689000.0 (Q4 2025), and 60834000.0 (Q3 2025), per Business Quant data.